Skip to main content
Erschienen in: Medical Oncology 1/2011

01.12.2011 | Review Article

Lymphoma of the breast in a male patient

verfasst von: Berna Bozkurt Duman, Berksoy Şahin, Birol Güvenç, Melek Ergin

Erschienen in: Medical Oncology | Sonderheft 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Primary lymphoma of the breast is very rare especially in a male patient. Treatment alternatives include surgery, chemotherapy, immunotherapy and radiation. It is still controversial which combination is the best. Here, we report a male patient who presented with a left breast mass. The excisional biopsy was applied, and pathological assessment revealed marginal zone lymphoma. Both conventional computed tomography and 18)F-Fluorodeoxyglucose positron emission tomography/computed tomography were used for staging. The clinical stage was IIE for Ann Arbor staging and so local radiation following chemo immunotherapy was planned. Left-sided primary breast lymphoma in a male patient is a very rare entity. Treatment modalities are still controversial. Some authors believe that primary breast lymphomas have poor prognosis, and they must be treated aggressively with combined treatment modalities. Another important point is that 18)F-Fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET)/CT could be used for staging of disease and assessing treatment response in a patient with primary breast marginal zone lymphoma.
Literatur
1.
Zurück zum Zitat Brogi E, Harris NL. Lymphomas of the breast: pathology and clinical behavior. Semin Oncol. 1999;26:357–64.PubMed Brogi E, Harris NL. Lymphomas of the breast: pathology and clinical behavior. Semin Oncol. 1999;26:357–64.PubMed
2.
Zurück zum Zitat Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of etranodal lymphomas. Cancer. 1972;29:252–60.PubMedCrossRef Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of etranodal lymphomas. Cancer. 1972;29:252–60.PubMedCrossRef
3.
4.
Zurück zum Zitat Mattia AR, Ferry JA, Harris NL. Breast lymphoma: a B-cell spectrum including the low grade B-cell lymphoma of mucosa associated lymphoid tissue. Am J Surg Pathol. 1993;17:574–87.PubMedCrossRef Mattia AR, Ferry JA, Harris NL. Breast lymphoma: a B-cell spectrum including the low grade B-cell lymphoma of mucosa associated lymphoid tissue. Am J Surg Pathol. 1993;17:574–87.PubMedCrossRef
6.
Zurück zum Zitat Mambo NC, Burke JS, Butler JJ. Primary malignant lymphoma of the breast. Cancer. 1977;39:2033–40.PubMedCrossRef Mambo NC, Burke JS, Butler JJ. Primary malignant lymphoma of the breast. Cancer. 1977;39:2033–40.PubMedCrossRef
7.
Zurück zum Zitat Barışta İ, Baltalı E, Tekuzman G, Kars A, Ruacan Ş, Özışık F, et al. Primary breast lymphomas. A retrospective analysis of twelve cases. Acta Oncol. 2000;39(2):135–9.PubMedCrossRef Barışta İ, Baltalı E, Tekuzman G, Kars A, Ruacan Ş, Özışık F, et al. Primary breast lymphomas. A retrospective analysis of twelve cases. Acta Oncol. 2000;39(2):135–9.PubMedCrossRef
8.
Zurück zum Zitat Suarez F, Lortholary O, Hermine O, Lecuit M. Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. Blood. 2006;107(8):3034–44.PubMedCrossRef Suarez F, Lortholary O, Hermine O, Lecuit M. Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. Blood. 2006;107(8):3034–44.PubMedCrossRef
9.
Zurück zum Zitat Elstrom R, Guan L, Baker G, Nakhoda G, Vergilio JA, Zhuang H, et al. Utility of FDG-PET scanning in lymphoma by WHO classification. Blood. 2003;101:3875–6.PubMedCrossRef Elstrom R, Guan L, Baker G, Nakhoda G, Vergilio JA, Zhuang H, et al. Utility of FDG-PET scanning in lymphoma by WHO classification. Blood. 2003;101:3875–6.PubMedCrossRef
10.
Zurück zum Zitat Kumar R, Maillard I, Schuster SJ, Alavi A. Utility of fluorodeoxyglucose-PET imaging in the management of patients with Hodgkin’s and non-Hodgkin’s lymphomas. Radiol Clin North Am. 2004;42:1083–100.PubMedCrossRef Kumar R, Maillard I, Schuster SJ, Alavi A. Utility of fluorodeoxyglucose-PET imaging in the management of patients with Hodgkin’s and non-Hodgkin’s lymphomas. Radiol Clin North Am. 2004;42:1083–100.PubMedCrossRef
11.
Zurück zum Zitat Friedber JW, Chengazi V. PET scans in the staging of lymphoma: current status. Oncologist. 2003;8:438–47.CrossRef Friedber JW, Chengazi V. PET scans in the staging of lymphoma: current status. Oncologist. 2003;8:438–47.CrossRef
12.
Zurück zum Zitat Alizarin L, Castelluci P, Elstrom R, Ambrosini V, Stefoni V, Nanni C, et al. 18 F-FDG PET in mucosa-associated lymphoid tissue (MALT) lymphoma. Leuk Lymphoma. 2006;47:2096–101.CrossRef Alizarin L, Castelluci P, Elstrom R, Ambrosini V, Stefoni V, Nanni C, et al. 18 F-FDG PET in mucosa-associated lymphoid tissue (MALT) lymphoma. Leuk Lymphoma. 2006;47:2096–101.CrossRef
13.
Zurück zum Zitat Schoder H, Noy A, Gonen M, Weng L, Green D, Erdi YE, et al. Intensity of 18 fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin’s lymphoma. J Clin Oncol. 2005;23:4643–51.PubMedCrossRef Schoder H, Noy A, Gonen M, Weng L, Green D, Erdi YE, et al. Intensity of 18 fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin’s lymphoma. J Clin Oncol. 2005;23:4643–51.PubMedCrossRef
14.
Zurück zum Zitat Perry C, Herishanu Y, Metzer U, Bairey O, Ruchlemer R, Trejo L, et al. Diagnostic accuracy of PET-BT in patients with extranodal marginal zone MALT lymphoma. Eur J Haematol. 2007;79(3):205–9.PubMedCrossRef Perry C, Herishanu Y, Metzer U, Bairey O, Ruchlemer R, Trejo L, et al. Diagnostic accuracy of PET-BT in patients with extranodal marginal zone MALT lymphoma. Eur J Haematol. 2007;79(3):205–9.PubMedCrossRef
15.
Zurück zum Zitat Von Schulthess GK, Steinert HC, Hany TF. Integrated PET/CT: current applications and future directions. Radiology. 2006;16:405–22.CrossRef Von Schulthess GK, Steinert HC, Hany TF. Integrated PET/CT: current applications and future directions. Radiology. 2006;16:405–22.CrossRef
16.
Zurück zum Zitat Kostakoglu L, Hardoff R, Mirtcheva R, Goldsmith SJ. PET-CT fusion imaging in differentiating physiological from pathological FDG uptake. Radiographics. 2004;24:1411–31.PubMedCrossRef Kostakoglu L, Hardoff R, Mirtcheva R, Goldsmith SJ. PET-CT fusion imaging in differentiating physiological from pathological FDG uptake. Radiographics. 2004;24:1411–31.PubMedCrossRef
17.
Zurück zum Zitat Wakabayashi H, Maeba T, Maeta H, Tanaka S. A case of primary malignant lymphoma of the bilateral breast. A study of surgical treatment based on the clinicopathological evaluation of its local involvement and postoperative recurrence site. Jpn J Breast Cancer. 1999;9:675–80. Wakabayashi H, Maeba T, Maeta H, Tanaka S. A case of primary malignant lymphoma of the bilateral breast. A study of surgical treatment based on the clinicopathological evaluation of its local involvement and postoperative recurrence site. Jpn J Breast Cancer. 1999;9:675–80.
18.
Zurück zum Zitat Brustein S, Kimmel M, Lieberman PH, Filippa DA, Rosen PP. Malignant lymphoma of the breast: a study of 53 patients. Ann Surg. 1997;205:144–50.CrossRef Brustein S, Kimmel M, Lieberman PH, Filippa DA, Rosen PP. Malignant lymphoma of the breast: a study of 53 patients. Ann Surg. 1997;205:144–50.CrossRef
19.
Zurück zum Zitat Uesato M, Miyazawa Y, Gunji Y, Orchiai T. Primary Non-Hodgkin’s lymphoma of the breast report of the breast report of a case with special reference to 380 cases in the Japanese literature. Breast Cancer. 2005;12(2):15–8.CrossRef Uesato M, Miyazawa Y, Gunji Y, Orchiai T. Primary Non-Hodgkin’s lymphoma of the breast report of the breast report of a case with special reference to 380 cases in the Japanese literature. Breast Cancer. 2005;12(2):15–8.CrossRef
20.
Zurück zum Zitat Miller TP, Dahlberg S, Robert Cassady J, Aldstein DJ, Spier CM, Grogan TM, et al. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate and high grade non Hodgkin’s lymphoma. N Eng J Med. 1998;339:21–6.CrossRef Miller TP, Dahlberg S, Robert Cassady J, Aldstein DJ, Spier CM, Grogan TM, et al. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate and high grade non Hodgkin’s lymphoma. N Eng J Med. 1998;339:21–6.CrossRef
21.
Zurück zum Zitat Tokui K, Sato M, Inoue H, Bando Y, Go S, Kimura S. A case of primary malignant lymphoma of the breast. Ehime Igaku. 1988;8:259–63. Tokui K, Sato M, Inoue H, Bando Y, Go S, Kimura S. A case of primary malignant lymphoma of the breast. Ehime Igaku. 1988;8:259–63.
22.
Zurück zum Zitat Kim SH, Ezekiel MP, Kim RY. Primary lymphoma of the breast. Am J Clin Oncol. 1999;22:381–3.PubMedCrossRef Kim SH, Ezekiel MP, Kim RY. Primary lymphoma of the breast. Am J Clin Oncol. 1999;22:381–3.PubMedCrossRef
23.
Zurück zum Zitat Ryan G, Martinelli G, Kuper-Hommel M, Tsang R, Pruneri G, Yuen K, et al. Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extra nodal Lymphoma Study Group. Ann Oncol. 2009;19:233–41.CrossRef Ryan G, Martinelli G, Kuper-Hommel M, Tsang R, Pruneri G, Yuen K, et al. Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extra nodal Lymphoma Study Group. Ann Oncol. 2009;19:233–41.CrossRef
24.
Zurück zum Zitat Martinelli G, Ryan G, Seymour JF, Nassi L, Steffanoni S, Alietti A, et al. Primary follicular an marginal-zone lymphoma of the breast: clinical features, prognostic factors and outcome: a study by the International Extra nodal Lymphoma Study Group. Ann Oncol. 2009 (Epub ahead of print). Martinelli G, Ryan G, Seymour JF, Nassi L, Steffanoni S, Alietti A, et al. Primary follicular an marginal-zone lymphoma of the breast: clinical features, prognostic factors and outcome: a study by the International Extra nodal Lymphoma Study Group. Ann Oncol. 2009 (Epub ahead of print).
25.
Zurück zum Zitat Conconi A, Martinelli G, Thieblemont C, et al. Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood. 2003;102:2741–5.PubMedCrossRef Conconi A, Martinelli G, Thieblemont C, et al. Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood. 2003;102:2741–5.PubMedCrossRef
26.
Zurück zum Zitat Giardini R, Piccolo C, Rilke F. Primary non-Hodgkin’s lymphomas of the female breast. Cancer. 1992;69:725–35.PubMedCrossRef Giardini R, Piccolo C, Rilke F. Primary non-Hodgkin’s lymphomas of the female breast. Cancer. 1992;69:725–35.PubMedCrossRef
27.
Zurück zum Zitat Abbondanzo SL, Seidman JD, Lefkowitz M, Tavassoli FA, Krishnan J. Primary diffuse large B-cell lymphoma of the breast. A clinicopathological study of 31 cases. Pathol Res Pract. 1996;192:37–43.PubMedCrossRef Abbondanzo SL, Seidman JD, Lefkowitz M, Tavassoli FA, Krishnan J. Primary diffuse large B-cell lymphoma of the breast. A clinicopathological study of 31 cases. Pathol Res Pract. 1996;192:37–43.PubMedCrossRef
28.
Zurück zum Zitat Kuper Hommel MJ, Snijder S, Janssen-Heijnen ML, Vrints LW, Kluin-Nelemans JC, Coebergh JW, et al. Treatment and survival of 38 breast lymphomas: a population based study with clinical and pathological reviews. Ann Hematol. 2003;82:397–404.PubMedCrossRef Kuper Hommel MJ, Snijder S, Janssen-Heijnen ML, Vrints LW, Kluin-Nelemans JC, Coebergh JW, et al. Treatment and survival of 38 breast lymphomas: a population based study with clinical and pathological reviews. Ann Hematol. 2003;82:397–404.PubMedCrossRef
29.
Zurück zum Zitat Gholam D, Bibeau F, Weshi El, Bosq J, Ribrag V. Primary breast lymphoma. Leuk Lymphoma. 2003;44:1173–8.PubMedCrossRef Gholam D, Bibeau F, Weshi El, Bosq J, Ribrag V. Primary breast lymphoma. Leuk Lymphoma. 2003;44:1173–8.PubMedCrossRef
30.
Zurück zum Zitat Liu MT, Hsieh CY, Wang AY, Pi CP, Chang TH, Huang CC, et al. Primary breast lymphoma: a pooled analysis of prognostic factors and survival 93 cases. Ann Saudi Med. 2005;25:288–93.PubMed Liu MT, Hsieh CY, Wang AY, Pi CP, Chang TH, Huang CC, et al. Primary breast lymphoma: a pooled analysis of prognostic factors and survival 93 cases. Ann Saudi Med. 2005;25:288–93.PubMed
31.
Zurück zum Zitat Lin YC, Tsai CH, Wu JS, Huang CS, Kuo SH, Lin CW, Cheng AL. Clinicopathological features and treatment outcome of non-Hodgkin lymphoma of the breast—a review of 42 primary and secondary cases in Taiwanese patients. Leuk Lymphoma. 2009;50(6):918–20.PubMedCrossRef Lin YC, Tsai CH, Wu JS, Huang CS, Kuo SH, Lin CW, Cheng AL. Clinicopathological features and treatment outcome of non-Hodgkin lymphoma of the breast—a review of 42 primary and secondary cases in Taiwanese patients. Leuk Lymphoma. 2009;50(6):918–20.PubMedCrossRef
Metadaten
Titel
Lymphoma of the breast in a male patient
verfasst von
Berna Bozkurt Duman
Berksoy Şahin
Birol Güvenç
Melek Ergin
Publikationsdatum
01.12.2011
Verlag
Springer US
Erschienen in
Medical Oncology / Ausgabe Sonderheft 1/2011
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-010-9675-0

Weitere Artikel der Sonderheft 1/2011

Medical Oncology 1/2011 Zur Ausgabe

PUBLISHER NOTE

Note from publisher

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.